News ResMed, Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:01 2024-04-26 pm EDT			5-day change	1st Jan Change
218.1 ^USD	+18.89%		+21.92%	+26.76%

09:58pm	Sector Update: Health Care Stocks Edge Higher Late Afternoon	MT
08:13pm	Top Midday Gainers	MT

Sector Update: Health Care Stocks Edge Higher Late Afternoon	03:58pm	MT
Top Midday Gainers	02:13pm	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	01:54pm	MT
In-Line Inflation Data, Tech Earnings Lift US Equity Indexes	01:35pm	MT
Sector Update: Health Care	01:33pm	MT
KeyBanc Adjusts Price Target on ResMed to $238 From $227	11:37am	MT
ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17%	11:04am	MT
Jefferies Adjusts Price Target on ResMed to $180 From $164	10:36am	MT
Oppenheimer Adjusts ResMed Price Target to $200 From $205, Maintains Outperform Rating	09:09am	MT
JPMorgan Adjusts Price Target on ResMed to $225 From $198	09:00am	MT
Mizuho Adjusts Price Target on ResMed to $220 From $215	08:09am	MT
Needham Adjusts Price Target on ResMed to $236 From $224	08:01am	MT
Morgan Stanley Adjusts Price Target on ResMed to $219 From $207	06:40am	MT
RBC Adjusts Price Target on ResMed to $200 From $187	06:18am	MT
ResMed Declares Quarterly Dividend as Fiscal Q3 Profit Jumps 29%; Shares Up 7%	11:21pm	MT
ResMed tops quarterly profit estimates on strong demand for sleep apnea devices	06:12pm	RE
ResMed : Q3 2024 ResMed Earnings Results Webcast Corporate 1-Pager	06:02pm	PU
ResMed : Q3 2024 ResMed Earnings Results Webcast Presentation	06:02pm	PU
ResMed Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Rise After Hours	Apr. 25	MT
Transcript : ResMed Inc., Q3 2024 Earnings Call, Apr 25, 2024	Apr. 25

No results for this search

ResMed, Inc. continues to make headway in the sleep market

December 11, 2023 at 05:55 am EST